Mario Schlosser Sells 31,422 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 31,422 shares of the company’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the sale, the director directly owned 449,444 shares of the company’s stock, valued at $14,135,013.80. This trade represents a 6.53% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The stock was sold at an average price of $30.79, for a total transaction of $4,618,500.00.
• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The shares were sold at an average price of $30.34, for a total value of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total transaction of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00.

Oscar Health Stock Up 2.0%

Shares of NYSE OSCR traded up $0.65 on Tuesday, reaching $32.90. 4,754,751 shares of the company’s stock traded hands, compared to its average volume of 7,062,275. The business’s 50 day simple moving average is $30.49 and its two-hundred day simple moving average is $22.87. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The company has a market cap of $10.15 billion, a price-to-earnings ratio of 23.50, a price-to-earnings-growth ratio of 0.66 and a beta of 2.37. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $33.55.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter last year, the company posted ($0.89) earnings per share. The firm’s quarterly revenue was up 70.4% on a year-over-year basis. As a group, equities research analysts forecast that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Large investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. grew its stake in Oscar Health by 11.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock worth $132,461,000 after buying an additional 910,320 shares during the last quarter. California State Teachers Retirement System boosted its holdings in Oscar Health by 3,214.2% in the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock worth $222,543,000 after acquiring an additional 7,567,600 shares in the last quarter. Morgan Stanley grew its stake in shares of Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after acquiring an additional 2,043,758 shares during the last quarter. Thrive Capital Management LLC grew its stake in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, BIT Capital GmbH increased its holdings in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after acquiring an additional 5,227,152 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $30.00 target price on shares of Oscar Health in a research report on Tuesday, August 11th. Wells Fargo & Company lifted their price target on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. Barclays boosted their price target on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Robert W. Baird set a $27.00 price objective on Oscar Health in a research report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.